Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hiroki Sugiyama
Effect of Vildagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Cardiac Hypertrophy Induced by Chronic Beta-Adrenergic Stimulation in Rats
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Related publications
Cardiac .BETA.-Adrenergic Signaling Pathway Alteration in Isoproterenol-Induced Cardiac Hypertrophy in Male Sprague-Dawley Rats.
Japanese Heart Journal
Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, Against Cisplatin-Induced Nephrotoxicity in Mice
Mediators of Inflammation
Immunology
Cell Biology
Orally Administered Dipeptidyl Peptidase-4 Inhibitor (Alogliptin) Prevents Abdominal Aortic Aneurysm Formation Through an Antioxidant Effect in Rats
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Suppression of Abdominal Aortic Aneurysm Formation in Mice by Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor
Journal of Atherosclerosis and Thrombosis
Biochemistry
Internal Medicine
Cardiovascular Medicine
Cardiology
Dipeptidyl Peptidase-4 (DPP-4; CD26)
Science-Business eXchange
Dipeptidyl Peptidase 4 Inhibitor Improves Brain Insulin Sensitivity, but Fails to Prevent Cognitive Impairment in Orchiectomy Obese Rats
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes